Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study

• Main Authors: Martina Tallarico (Author), Caterina Palleria (Author), Livia Ruffolo (Author), Rocco Spagnuolo (Author), Maria Diana Naturale (Author), Adele Emanuela De Francesco (Author), Caterina De Sarro (Author), Rossella Romeo (Author), Rita Citraro (Author), Patrizia Doldo (Author), Ludovico Abenavoli (Author), Luca Gallelli (Author), Francesco Luzza (Author), Antonio Leo (Author), Giovambattista De Sarro (Author)
• Format: Book
• Published: MDPI AG, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The use of immune-modifying biological agents has markedly changed the clinical course and the management of Inflammatory bowel diseases (IBDs). Active post-marketing surveillance programs are fundamental to early recognize expected and unexpected adverse events (AEs), representing a pow...